To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Department of Health and Social Care: Women
Monday 23rd October 2023

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what proportion of civil servants on temporary contracts in his Department are women.

Answered by Will Quince

As of 30 September 2023, 62% of the Department’s workforce on temporary contracts were women.


Written Question
Department of Health and Social Care: Women
Monday 23rd October 2023

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what proportion of civil servants (a) at grade senior civil servant 2 and (b) on full-time equivalent contracts in his Department are women.

Answered by Will Quince

The following table shows the gender split of senior civil servant (SCS) 2 civil servants within the Department as of 30 September 2023. 47% of our SCS 2 cadre are female. Of that 47% that are female, 43% are full-time.

SCS 2

Male

Female

Grand Total

Full-time

45%

43%

88%

Part-time

8%

4%

12%

Grand Total

53%

47%

100%


Written Question
Cancer: Children and Young People
Tuesday 28th March 2023

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the needs of children and young people with cancer are met in the Major Conditions Strategy.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

The Major Conditions Strategy will look at the treatment and prevention of cancer in people of all ages, covering the patient pathway. The strategy will look at a wide range of interventions and enablers to improve outcomes and experience for cancer patients.

This Strategy will draw on previous work on cancer, including over 5,000 submissions provided to the Department as part of our Call for Evidence last year.  We will continue to work closely with stakeholders, citizens and the National Health Service in the coming weeks to identify actions for the Strategy that will have the most impact.


Written Question
Cancer: Children and Young People
Tuesday 28th March 2023

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how the Major Conditions Strategy will address the psychological needs of children, teenagers and young adults with cancer.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

The Major Conditions Strategy will look at the treatment and prevention of cancer in people of all ages, covering the patient pathway. The strategy will look at a wide range of interventions and enablers to improve outcomes and experience for cancer patients.

This Strategy will draw on previous work on cancer, including over 5,000 submissions provided to the Department as part of our Call for Evidence last year.  We will continue to work closely with stakeholders, citizens and the National Health Service in the coming weeks to identify actions for the Strategy that will have the most impact.


Written Question
Radioisotopes
Monday 6th March 2023

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to improve the (a) medium-term and (b) long-term sustainability of the supply of (i) Molybdenum-99 generators, (ii) Iodine-131medical grade radioisotopes and (iii) other medical grade radioisotopes.

Answered by Will Quince

We are working closely with officials in the Department for Energy Security and Net Zero who are leading a £6 million funded Medical Radionuclide Innovation Programme. This is focused on safeguarding the provision and development of radiopharmaceuticals for United Kingdom patients in the medium and long-term and encouraging innovation in technologies and techniques that could support access to radioisotopes in order to increase the UK’s resilience in times of global supply constraints or shortages. The Department for Energy Security and Net Zero has commissioned a landscape assessment to inform Government action in this area.

We routinely monitor short-term threats to the supply of medical grade radioisotopes, including through regular contact with UK suppliers, and has well-established processes which aim to prevent supply issues occurring in the first instance, and to manage or mitigate them when they occur. There are currently no active UK supply issues with medical radioisotopes.


Written Question
Radioisotopes
Monday 6th March 2023

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the level of medical grade radioisotopes in the UK including (a) Molybdenum-99 generators and and (b) Iodine-131.

Answered by Will Quince

We are working closely with officials in the Department for Energy Security and Net Zero who are leading a £6 million funded Medical Radionuclide Innovation Programme. This is focused on safeguarding the provision and development of radiopharmaceuticals for United Kingdom patients in the medium and long-term and encouraging innovation in technologies and techniques that could support access to radioisotopes in order to increase the UK’s resilience in times of global supply constraints or shortages. The Department for Energy Security and Net Zero has commissioned a landscape assessment to inform Government action in this area.

We routinely monitor short-term threats to the supply of medical grade radioisotopes, including through regular contact with UK suppliers, and has well-established processes which aim to prevent supply issues occurring in the first instance, and to manage or mitigate them when they occur. There are currently no active UK supply issues with medical radioisotopes.


Written Question
Sunscreen: Prices
Monday 27th February 2023

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the price of sunscreen on the rate of people wearing sunscreen and the risk of cancer among those who do not wear it.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

No specific assessment has been made.


Written Question
Huntington's Disease: Research
Monday 21st November 2022

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of public funding for the research of (a) adult- and (b) juvenile-onset Huntington’s disease.

Answered by Will Quince

The Government primarily funds research into rare conditions, such as Huntington’s disease and Juvenile-onset Huntington’s disease, via the National Institute for Health and Care Research (NIHR) and UK Research and Innovation (UKRI).

From 2017/18 to 2021/22, funding for research into Huntington’s disease was £32.6 million and in 2021/22, expenditure was £4.9 million. The NIHR and UKRI welcome funding applications for research into any aspect of human health, including adult Huntington’s disease and Juvenile-onset Huntington’s disease. While it is not usual practice to ring-fence funds for particular topics or conditions, the NIHR and UKRI award funding through open competition to ensure the highest quality research is funded.


Written Question
Huntington's Disease: Health Services
Friday 18th November 2022

Asked by: Amy Callaghan (Scottish National Party - East Dunbartonshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has held discussions with the devolved administrations on developing consistent guidance and support for people with Huntington's disease.

Answered by Helen Whately - Minister of State (Department of Health and Social Care)

While there have been no specific discussions, we regularly engage with the devolved administrations on support for people with rare conditions, such as Huntington’s disease.

The UK Rare Diseases Framework, published in January 2021, sets out the ambition to improve the lives of those with rare diseases. The nation-specific action plans provide details on how each administration will meet the shared priorities of the Framework.


Speech in Westminster Hall - Tue 08 Nov 2022
Pancreatic Cancer Awareness Month

Speech Link

View all Amy Callaghan (SNP - East Dunbartonshire) contributions to the debate on: Pancreatic Cancer Awareness Month